You are viewing the site in preview mode
Skip to main content
CD8+
CD3+
CD45RO+
Parameters
No (%)
Mean (SD)
p
Mean (SD)
p
Mean (SD)
p
Age
0.27
0.30
0.37
< 50
18 (47.4 %)
15.1 (10.2)
39.1 (23.6)
34.6 (30.9)
50+
20 (52.6 %)
19.7 (12.2)
48.0 (26.7)
42.6 (22.6)
Gender
Female
43 (100.0 %)
16.7 (11.3)
43.2 (25.3)
38.2 (26.1)
Diagnosis
0.09
0.35
0.24
IDC
38 (88.4 %)
18.1 (11.1)
44.1 (25.3)
36.5 (26.8)
ILC
3 (7.0 %)
4.5 (2.3)
50.0 (26.2)
62.7 (3.1)
Others
2 (4.7 %)
10.5 (13.4)
18.5 (19.1)
33.0 (7.1)
Grade
0.48
0.14
0.44
1
5 (11.6 %)
11.0 (6.9)
33.2 (25.2)
38.4 (19.0)
2
23 (53.5 %)
18.0 (9.9)
50.4 (26.2)
42.5 (25.2)
3
15 (34.9 %)
16.9 (14.0)
34.9 (21.3)
31.0 (29.6)
LVI
0.39
0.12
0.21
Positive
18 (41.9 %)
14.9 (11.5)
36.1 (25.8)
32.3 (28.6)
Negative
25 (58.1 %)
18.0 (11.2)
48.5 (24.0)
42.6 (23.8)
Lymph node
0.29
0.04
0.32
Positive
19 (63.3 %)
17.7 (10.1)
47.9 (28.2)
41.5 (28.1)
Negative
11 (36.7 %)
13.3 (11.1)
30.6 (13.8)
30.7 (27.1)
Estrogen receptor
0.086
0.87
0.74
Positive
25 (58.1 %)
13.8 (7.3)
42.7 (26.4)
37.0 (22.4)
Negative
18 (41.9 %)
20.7 (14.5)
44.0 (24.4)
39.9 (31.4)
Progesterone receptor
0.086
0.87
0.74
Positive
25 (58.1 %)
13.8 (7.3)
42.7 (26.4)
37.0 (22.4)
Negative
18 (41.9 %)
20.7 (14.5)
44.0 (24.4)
39.9 (31.4)
HER2/neu
0.006
0.83
0.56
Positive
11 (25.6 %)
24.5 (13.5)
44.7 (25.0)
33.9 (26.3)
Negative
32 (74.4 %)
13.8 (9.0)
42.7 (25.8)
39.5 (26.3)
Molecular subtype
0.034
0.48
0.82
Luminal Aa
23 (53.5 %)
13.5 (7.4)
44.7 (26.7)
37.3 (23.3)
Luminal Bb
2 (4.7 %)
17.0 (8.5)
21.5 (9.2)
34.0 (5.7)
TNBCc
9 (20.9 %)
14.5 (13.0)
38.2 (24.3)
45.3 (33.6)
HER2/neu Positived
9 (20.9 %)
26.1 (14.2)
50.5 (24.5)
33.9 (29.8)
IDC Invasive ductal carcinoma, ILC Invasive lobular carcinoma, SD standard deviation, LVI Lymphovascular invasion
a Luminal A = ER (+ve) and/or PR (+ve) and HER2/neu (−ve); b Luminal B = ER (+ve) and/or PR (+ve) and HER2/neu (+ve); c TNBC: Triple negative = ER (−ve) and/or PR (−ve) and HER2/neu (−ve); d HER2/neu positive = ER (−ve) and/or PR (−ve) and HER2/neu (+ve)
